ALDH2 and myocardial infarction: Overexpression of ALDH2 in a mouse model or enhancement of its activity via the small-molecular activator Alda-1 diminished myocardial infarct size, prevented the progression of ventricular remodeling and improved the long-term survival after I/R [25,43,44].